Clinical benefits of LAFOV PET/CT in growing demand for molecular imaging

Eur J Nucl Med Mol Imaging. 2025 Feb 27. doi: 10.1007/s00259-025-07159-5. Online ahead of print.

Wouter V Vogel^{1

2}, Milou M Steemers-de Boer³, Sanne M Jansen^{3

4}, Erik-Jan Rijkhorst⁵, Berlinda J de Wit-van der Veen³, Bernies van der Hiel³, Arthur J A T Braat^{3

6}

¹ Department of Nuclear Medicine, NKI-AVL, Amsterdam, The Netherlands. w.vogel@nki.nl.
² Department of Radiation Oncology, NKI-AVL, Amsterdam, The Netherlands. w.vogel@nki.nl.
³ Department of Nuclear Medicine, NKI-AVL, Amsterdam, The Netherlands.
⁴ Department of Radiology, NKI-AVL, Amsterdam, The Netherlands.
⁵ Department of Medical Physics and Technology, NKI-AVL, Amsterdam, The Netherlands.
⁶ Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht, The Netherlands.

No abstract available

Keywords: LAFOV PET/CT; Molecular imaging.

Publication types